Onconetix (ONCO) Stock Statistics & Valuation Metrics

Onconetix has a market cap or net worth of $1.94M. The enterprise value is $9.83M.

Onconetix has 521,863 shares outstanding. The number of shares has decreased by -2.65% in one year.

Onconetix’s return on equity (ROE) is -6.11 and return on invested capital (ROIC) is -286.99%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Onconetix had revenue of 2.52M and earned -58.69M in profits. Earnings per share was -1.82K.

In the last 12 months, operating cash flow was -7.26M and capital expenditures -23.89K, giving a free cash flow of -7.29M billion.

Onconetix pays an annual dividend of ―, resulting in a dividend yield of ―

Onconetix upcoming earnings date is ―, ―.

Onconetix as a current ratio of 0.05, with Debt / Equity ratio of 200.26%

In the past 12 months, Onconetix has paid -1.05M in taxes.

Onconetix EV to EBITDA ratio is -0.18, with an EV/FCF ratio of -1.00.

Onconetix has $1.58M in cash and marketable securities with $9.05M in debt, giving a net cash position of $7.47M billion.

Gross margin is 47.37%, with operating margin of -2237.96%, and net profit margin of -2325.21%.

The average price target for Onconetix is ―, which is 11.43% higher than the current price. The consensus rating is ―